ArticleHeart and vessels2026
Clinical course after cardiac resynchronization therapy in transthyretin amyloid cardiomyopathy receiving disease-modifying therapy.
Shuichiro Yamauchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it